eli lilly and tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply access for adults living with obesity FDA approves tirzepatide, Eli Lilly's

You will get an injection (shot) of long-acting lidocaine to help manage your pain

For patients on antithyroid medications, maintain the established monitoring schedule with emphasis on free T4 and T3 levels early in treatment

Haziness, milkiness, or opaque appearance suggests protein aggregation or particulate matter

2 The FDA approval of Wegovy HD is based on the results of the STEP UP trial program, which included STEP UP, a 72-week study which evaluated the efficacy and safety of once-weekly Wegovy 7.2 mg compared to placebo and Wegovy 2.4 mg, as an adjunct to lifestyle intervention in 1,407 adults with obesity (BMI 30 kg/m 2 or greater), without diabetes